First published 9/30/2026, 12:07:15 AM · Last updated 9/30/2026, 12:07:15 AM

Skin Adverse Events Linked to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis Using FAERS and Drug–Gene Interaction Network Analyses

IMR Press published a journal article reporting a disproportionality analysis of skin adverse events linked to epidermal growth factor receptor tyrosine kinase inhibitors using FAERS and drug–gene interaction network analyses. The supplied record contains only the title, publisher, and publication date without study results or details.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 4/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 2/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 2/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 1/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article concerns adverse skin events associated with EGFR tyrosine kinase inhibitors, a drug-safety topic.

Sources

Skin Adverse Events Linked to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis Using FAERS and Drug–Gene Interaction Network Analyses

Report an issue